Complement dysregulation in haemolytic uraemic syndrome

被引:8
作者
Bonnardeaux, A [1 ]
Pichette, V [1 ]
机构
[1] Univ Montreal, Hop Maison Neuve Rosemont, Serv Nephrol, Montreal, PQ H1T 2M4, Canada
关键词
D O I
10.1016/S0140-6736(03)14777-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1514 / 1515
页数:2
相关论文
共 9 条
[1]  
CAPRIOLI J, 2003, HUM MOL GENET 1028
[2]   Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor [J].
Donne, RL ;
Abbs, I ;
Barany, P ;
Elinder, CG ;
Little, M ;
Conlon, P ;
Goodship, THJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (06)
[3]   Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome - A systematic review, meta-analysis, and meta-regression [J].
Garg, AX ;
Suri, RS ;
Barrowman, N ;
Rehman, F ;
Matsell, D ;
Rosas-Arellano, MP ;
Salvadori, M ;
Haynes, RB ;
Clark, WF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (10) :1360-1370
[4]   The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children [J].
Loirat, C ;
Niaudet, P .
PEDIATRIC NEPHROLOGY, 2003, 18 (11) :1095-1101
[5]   FAMILIAL HEMOLYTIC-UREMIC SYNDROME AND HOMOZYGOUS FACTOR-H DEFICIENCY [J].
PICHETTE, V ;
QUERIN, S ;
SCHURCH, W ;
BRUN, G ;
LEHNERNETSCH, G ;
DELAGE, JM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (06) :936-941
[6]   Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome [J].
Richards, A ;
Kemp, EJ ;
Liszewski, MK ;
Goodship, JA ;
Lampe, AK ;
Decorte, R ;
Müslümanoglu, MH ;
Kavukcu, S ;
Filler, G ;
Pirson, Y ;
Wen, LS ;
Atkinson, JP ;
Goodship, THJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (22) :12966-12971
[7]   Post-transplant hemolytic-uremic syndrome [J].
Ruggenenti, P ;
Noris, M ;
Cohen, JJ ;
Schieppati, A ;
Remuzzi, G ;
Perico, N ;
Zoja, C ;
Gregorini, G ;
Galbusera, M .
KIDNEY INTERNATIONAL, 2002, 62 (03) :1093-1104
[8]   Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura [J].
Ruggenenti, P ;
Noris, M ;
Remuzzi, G .
KIDNEY INTERNATIONAL, 2001, 60 (03) :831-846
[9]   Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome [J].
Veyradier, A ;
Obert, B ;
Haddad, E ;
Cloarec, S ;
Nivet, H ;
Foulard, M ;
Lesure, F ;
Delattre, P ;
Lakhdari, M ;
Meyer, D ;
Girma, JP ;
Loriat, C .
JOURNAL OF PEDIATRICS, 2003, 142 (03) :310-317